Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 114 results.
User Information
Export Records
  1. 1.   Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients
  2. Ivison, Geoffrey T; Vendrame, Elena; Martínez-Colón, Giovanny J; Ranganath, Thanmayi; Vergara, Rosemary; Zhao, Nancy Q; Martin,Pat; Bendall, Sean C; Carrington,Mary; Cyktor, Joshua C; McMahon, Deborah K; Eron, Joseph; Jones, R Brad; Mellors, John W; Bosch, Ronald J; Gandhi, Rajesh T; Holmes, Susan; Blish, Catherine A
  3. Frontiers in Cellular and Infection Microbiology. 2022 12: 757846.
  1. 2.   The conserved C2 phospholipid-binding domain in Delta contributes to robust Notch signalling
  2. Martins, Torcato; Meng, Yao; Korona, Boguslawa; Suckling, Richard; Johnson, Steven; Handford, Penny A.; Lea,Susan; Bray, Sarah J.
  3. EMBO REPORTS. 2021, Aug 4;
  1. 3.   High-efficiency enrichment enables identification of aptamers to circulating Plasmodium falciparum-infected erythrocytes
  2. Oteng, Eugene K; Gu, Wenjuan; McKeague, Maureen
  3. Scientific reports. 2020, Jun 16; 10(1): 9706.
  1. 4.   Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption
  2. Mitchell, Julie L.; Takata, Hiroshi; Muir, Roshell; Colby, Donn J.; Kroon, Eugene; Crowell, Trevor A.; Sacdalan, Carlo; Pinyakorn, Suteeraporn; Puttamaswin, Suwanna; Benjapornpong, Khunthalee; Trichavaroj, Rapee; Tressler, Randall L.; Fox, Lawrence; Polonis, Victoria R.; Bolton, Diane L.; Maldarelli,Frank; Lewin, Sharon R.; Haddad, Elias K.; Phanuphak, Praphan; Robb, Merlin L.; Michael, Nelson L.; de Souza, Mark; Phanuphak, Nittaya; Ananworanich, Jintanat; Trautmann, Lydie
  3. JOURNAL OF CLINICAL INVESTIGATION. 2020, JUN 1; 130(6): 2845-2858.
  1. 5.   Modeling ligand docking to RNA in the design of RNA-based nanostructures
  2. Kasprzak,Wojciech; Ahmed, Nour Ali; Shapiro,Bruce
  3. Current opinion in biotechnology. 2020, JUN; 63: 16-25.
  1. 6.   Chemotactic Ligands that Activate G-Protein-Coupled Formylpeptide Receptors
  2. Krepel,Stacey; Wang,Jiming
  3. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2019, Jul; 20(14):
  1. 7.   PDB Ligand Conformational Energies Calculated Quantum-Mechanically
  2. Sitzmann, M.; Weidlich, I. E.; Filippov, I. V.; Liao, C.; Peach, M. L.; Ihlenfeldt, W. D.; Karki, R. G.; Borodina, Y. V.; Cachau, R. E.; Nicklaus, M. C.
  3. Journal of Chemical Information and Modeling. 2012, Mar; 52(3): 739-756.
  1. 8.   Diversity of the KIR gene cluster in an urban Brazilian population
  2. Augusto, D. G.; Zehnder-Alves, L.; Pincerati, M. R.; Martin, M. P.; Carrington, M.; Petzl-Erler, M. L.
  3. Immunogenetics. 2012, Feb; 64(2): 143-152.
  1. 9.   Non-SH2/PDZ reverse signaling by ephrins
  2. Daar, I. O.
  3. Seminars in Cell & Developmental Biology. 2012, Feb; 23(1): 65-74.
  1. 10.   CCR6/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues
  2. Sisirak, V.; Vey, N.; Vanbervliet, B.; Duhen, T.; Puisieux, I.; Homey, B.; Bowman, E. P.; Trinchieri, G.; Dubois, B.; Kaiserlian, D.; Lira, S. A.; Puisieux, A.; Blay, J. Y.; Caux, C.; Bendriss-Vermare, N.
  3. Blood. 2011, Nov; 118(19): 5130-5140.
  1. 11.   Multiple-Targeting and Conformational Selection in the Estrogen Receptor: Computation and Experiment
  2. Yuan, P.; Liang, K. W.; Ma, B. Y.; Zheng, N.; Nussinov, R.; Huang, J.
  3. Chemical Biology & Drug Design. 2011, Jul; 78(1): 137-149.
  1. 12.   Software and resources for computational medicinal chemistry
  2. Liao, C. Z.; Sitzmann, M.; Pugliese, A.; Nicklaus, M. C.
  3. Future Medicinal Chemistry. 2011, Jun; 3(8): 1057-1085.
  1. 13.   Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10
  2. Rodriguez-Garcia, M.; Porichis, F.; de Jong, O. G.; Levi, K.; Diefenbach, T. J.; Lifson, J. D.; Freeman, G. J.; Walker, B. D.; Kaufmann, D. E.; Kavanagh, D. G.
  3. Journal of Leukocyte Biology. 2011, Apr; 89(4): 507-515.
  1. 14.   EphrinB1 interacts with the transcriptional co-repressor Groucho/xTLE4
  2. Kamata, T.; Bong, Y. S.; Mood, K.; Park, M. J.; Nishanian, T. G.; Lee, H. S.
  3. Bmb Reports. 2011, Mar; 44(3): 199-204.
  1. 15.   Allostery and population shift in drug discovery
  2. Kar, G.; Keskin, O.; Gursoy, A.; Nussinov, R.
  3. Current Opinion in Pharmacology. 2010, Dec; 10(6): 715-722.
  1. 16.   Structure of the Taz2 domain of p300: insights into ligand binding
  2. Miller, M.; Dauter, Z.; Cherry, S.; Tropea, J. E.; Wlodawer, A.
  3. Acta crystallographica. Section D, Biological crystallography. 2009, Dec; 65(Pt 12): 1301-8.
  1. 17.   IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding
  2. Cer, R. Z.; Mudunuri, U.; Stephens, R.; Lebeda, F. J.
  3. Nucleic Acids Research. 2009 37(Web Server issue): W441-W445.
  1. 18.   Fibroblast Growth Factor Receptor-induced Phosphorylation of EphrinB1 Modulates Its Interaction with Dishevelled
  2. Lee, H. S.; Mood, K.; Battu, G.; Ji, Y. J.; Singh, A.; Daar, I. O.
  3. Molecular Biology of the Cell. 2009 20(1): 124-133.
  1. 19.   Novel Broad-Spectrum Bis-(Imidazolinylindole) Derivatives with Potent Antibacterial Activities against Antibiotic-Resistant Strains
  2. Panchal, R. G.; Ulrich, R. L.; Lane, D.; Butler, M. M.; Houseweart, C.; Opperman, T.; Williams, J. D.; Peet, N. P.; Moir, D. T.; Nguyen, T.; Gussio, R.; Bowlin, T.; Bavari, S.
  3. Antimicrobial Agents and Chemotherapy. 2009 53(10): 4283-4291.
  1. 20.   Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses
  2. Ahlenstiel, G.; Martin, M. P.; Gao, X. J.; Carrington, M.; Rehermann, B.
  3. Journal of Clinical Investigation. 2008 118(3): 1017-1026.
  1. 21.   Selectivity and Mechanism of Action of a Growth Factor Receptor-Bound Protein 2 Src Homology 2 Domain Binding Antagonist
  2. Giubellino, A.; Shi, Z. D.; Jenkins, L.; Worthy, K. M.; Bindu, L. K.; Athauda, G.; Peruzzi, B.; Fisher, R. J.; Appella, E.; Burke, T. R.; Bottaro, D. P.
  3. Journal of Medicinal Chemistry. 2008 51(23): 7459-7468.
  1. 22.   Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging
  2. Lee, S. B.; Hassan, M.; Fisher, R.; Chertov, O.; Chernomordik, V.; Kramer-Marek, G.; Gandjbakhche, A.; Capala, J.
  3. Clinical Cancer Research. 2008 14(12): 3840-3849.
  1. 23.   A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agents
  2. Regino, C.; Walbridge, S.; Bernardo, M.; Wong, K. J.; Johnson, D.; Lonser, R.; Oldfield, E. H.; Choyke, P. L.; Brechbiel, M. W.
  3. Contrast Media & Molecular Imaging. 2008 3(1): 2-8.
  1. 24.   Toll-like receptors in inflammation, infection and cancer
  2. Chen, K. Q.; Huang, J.; Gong, W. H.; Iribarren, P.; Dunlop, N. M.; Wang, J. M.
  3. International Immunopharmacology. 2007, Oct; 7(10): 1271-1285.
  1. 25.   EphrinB1 signals from the cell surface to the nucleus by recruitment of STAT3
  2. Bong, Y. S.; Lee, H. S.; Carim-Todd, L.; Mood, K.; Nishanian, T. G.; Tessarollo, L.; Daar, I. O.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, Oct; 104(44): 17305-17310.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel